Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway; Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, MD, USA.
Vaccine. 2019 Aug 7;37(34):4794-4799. doi: 10.1016/j.vaccine.2019.01.003. Epub 2019 Jan 29.
In the absence of good animal models, Controlled Human Infection Models (CHIMs) are useful to assess efficacy of new vaccine candidates against Enterotoxic Escherichia coli (ETEC), as well as other preventive or therapeutic interventions. At the 2018 Vaccines Against Shigella and ETEC (VASE) conference, a workshop was held to further review and discuss new challenge model developments and key issues related to further model standardization. During the workshop, invited speakers briefly summarized for attendees recent developments and main agenda issues before workshop participants were divided into four groups for more focused discussions. The main issues discussed were: (1) whether there is a need for more ETEC strains to test a diversity of vaccine candidates, and if so, what criteria/qualities are desirable in strain selection; (2) how ETEC CHIMs could be more standardized to better support ETEC vaccine development; (3) how volunteer selection criteria and screening should be performed, and; (4) how an expanded sample collection schema and collaborative analysis plan may facilitate a more in-depth assessment of the role of antigen-specific humoral and cellular immune responses in ETEC infection, and provide better insights into ETEC pathogenesis and correlates of protection. The workshop concluded that additional challenge strains may need to be developed to better support new vaccines and therapeutics that are advancing in the development pipeline. In this regard, the need for a well characterized ST-only expressing ETEC strain was highlighted as a priority given that promising new heat stable toxoid based vaccine candidates are on the horizon. In addition, further standardization of the ETEC CHIMs was strongly encouraged, noting that it may not be realistic to standardize across all strains. Also, intensified volunteer screening may result in higher attack rates, although more stringent eligibility criteria may contribute to a more limited application of the model and diminish its representativeness. Finally, a sampling schedule and priority list for minimum set of samples was also proposed. Future workshops could be held to further refine standards for ETEC CHIMS and to facilitate more collaborative work on stored sample sets from previous and future ETEC CHIMs to maximize the contribution of these trials to our understanding of ETEC pathogenesis and our development of better prevention and control measures for this important pathogen.
在缺乏良好的动物模型的情况下,受控人体感染模型(CHIM)可用于评估针对肠毒性大肠杆菌(ETEC)的新型疫苗候选物的功效,以及其他预防或治疗干预措施。在 2018 年针对志贺氏菌和 ETEC 的疫苗(VASE)会议上,举办了一个研讨会,以进一步审查和讨论新的挑战模型的发展以及与进一步模型标准化相关的关键问题。在研讨会上,受邀演讲者简要地向与会者总结了研讨会之前的最新进展和主要议程问题,然后将研讨会参与者分成四组进行更集中的讨论。讨论的主要问题是:(1)是否需要更多的 ETEC 菌株来测试多种疫苗候选物,如果需要,在菌株选择方面需要什么标准/质量;(2)如何使 ETEC CHIM 更加标准化,以更好地支持 ETEC 疫苗的开发;(3)如何进行志愿者选择标准和筛选;(4)如何扩大样本采集方案和协作分析计划,以促进对 ETEC 感染中抗原特异性体液和细胞免疫反应的作用进行更深入的评估,并更好地了解 ETEC 的发病机制和保护相关性。研讨会得出的结论是,可能需要开发更多的挑战菌株,以更好地支持正在研发管道中推进的新型疫苗和疗法。在这方面,强调需要开发一种具有良好特征的仅表达 ST 的 ETEC 菌株,因为有前途的新型耐热毒素疫苗候选物即将面世。此外,强烈鼓励进一步标准化 ETEC CHIM,指出跨所有菌株进行标准化可能不切实际。此外,加强志愿者筛选可能会导致更高的攻击率,尽管更严格的资格标准可能会导致该模型的应用范围有限,并降低其代表性。最后,还提出了一个样本采集时间表和最低样本集的优先级列表。未来可能会举行更多的研讨会,以进一步细化 ETEC CHIMS 的标准,并促进对以前和未来的 ETEC CHIM 中存储的样本集进行更多的协作工作,以最大限度地发挥这些试验对我们理解 ETEC 发病机制以及为这种重要病原体开发更好的预防和控制措施的贡献。